Welcome to LookChem.com Sign In|Join Free

CAS

  • or
AB-FUBINACA, also known as N-[(1S)-1-(Aminocarbonyl)-2-methylpropyl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide, is an indazole derivative developed as a CB1 receptor modulator. It is primarily used in the treatment of CB1-mediated diseases.

1185282-01-2 Suppliers

This product is a nationally controlled contraband or patented product, and the Lookchem platform doesn't provide relevant sales information.
  • 1185282-01-2 Structure
  • Basic information

    1. Product Name: AB-FUBINACA
    2. Synonyms: AB-FUBINACA;N-[(1S)-1-(aMinocarbonyl)-2-Methylpropyl]-1-[(4-fluorophenyl)Methyl]-1H-indazole-3-carboxaMide;(S)-N-(1-aMino-3-Methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxaMide;N-[(1S)-1-(aMinocarbonyl)-2-Methylpropyl]-1-(4-fluorobenzyl)-1H-indazole-3-carboxaMide;AB-FUBINACA solution;N-[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]-1-[(4-fluorophenyl)methyl]indazole-3-carboxamide;N-[(1S)-1-carbamoyl-2-methyl-propyl]-1-[(4-fluorophenyl)methyl]indazole-3-carboxamide
    3. CAS NO:1185282-01-2
    4. Molecular Formula: C20H21FN4O2
    5. Molecular Weight: 368.4047432
    6. EINECS: 200-659-6
    7. Product Categories: Food additives
    8. Mol File: 1185282-01-2.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: 9℃
    4. Appearance: /
    5. Density: 1.30±0.1 g/cm3 (20 oC 760 Torr)
    6. Refractive Index: N/A
    7. Storage Temp.: ?20°C
    8. Solubility: N/A
    9. CAS DataBase Reference: AB-FUBINACA(CAS DataBase Reference)
    10. NIST Chemistry Reference: AB-FUBINACA(1185282-01-2)
    11. EPA Substance Registry System: AB-FUBINACA(1185282-01-2)
  • Safety Data

    1. Hazard Codes: F,T
    2. Statements: 11-23/24/25-39/23/24/25
    3. Safety Statements: 7-16-36/37-45
    4. RIDADR: UN1230 - class 3 - PG 2 - Methanol, solution
    5. WGK Germany: 1
    6. RTECS:
    7. HazardClass: N/A
    8. PackingGroup: N/A
    9. Hazardous Substances Data: 1185282-01-2(Hazardous Substances Data)

1185282-01-2 Usage

Uses

Used in Pharmaceutical Industry:
AB-FUBINACA is used as a CB1 receptor modulator for the treatment of CB1-mediated diseases. Its mechanism of action involves targeting the CB1 receptor, which plays a crucial role in various physiological processes and disease conditions. By modulating the CB1 receptor, AB-FUBINACA can potentially provide therapeutic benefits for patients suffering from these diseases.

Check Digit Verification of cas no

The CAS Registry Mumber 1185282-01-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,8,5,2,8 and 2 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1185282-01:
(9*1)+(8*1)+(7*8)+(6*5)+(5*2)+(4*8)+(3*2)+(2*0)+(1*1)=152
152 % 10 = 2
So 1185282-01-2 is a valid CAS Registry Number.

1185282-01-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name N-[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]-1-[(4-fluorophenyl)methyl]indazole-3-carboxamide

1.2 Other means of identification

Product number -
Other names AB-FUBINACA

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1185282-01-2 SDS

1185282-01-2Downstream Products

1185282-01-2Relevant articles and documents

INDAZOLE DERIVATIVES

-

Page/Page column 34, (2011/02/25)

This invention relates to compounds, pharmaceutical compositions and methods for the treatment of a condition mediated by CB1 receptor activity in a mammalian subject including a human, which comprises administering to a mammal in need of such treatment a